276.67
price down icon0.54%   -1.50
after-market アフターアワーズ: 276.67
loading
前日終値:
$278.17
開ける:
$277.6
24時間の取引高:
1.64M
Relative Volume:
0.58
時価総額:
$41.78B
収益:
$4.39B
当期純損益:
$853.00M
株価収益率:
50.22
EPS:
5.5097
ネットキャッシュフロー:
$556.00M
1週間 パフォーマンス:
-5.80%
1か月 パフォーマンス:
+34.01%
6か月 パフォーマンス:
+128.79%
1年 パフォーマンス:
+194.77%
1日の値動き範囲:
Value
$268.52
$278.00
1週間の範囲:
Value
$254.00
$309.35
52週間の値動き範囲:
Value
$88.00
$309.35

Illumina Inc Stock (ILMN) Company Profile

Name
名前
Illumina Inc
Name
セクター
Healthcare (1051)
Name
電話
(858) 202-4500
Name
住所
5200 ILLUMINA WAY, SAN DIEGO, CA
Name
職員
8,600
Name
Twitter
@illumina
Name
次回の収益日
2026-10-29
Name
最新のSEC提出書
Name
ILMN's Discussions on Twitter

Compare ILMN vs TMO, DHR, NTRA, A, IQV

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
ILMN icon
ILMN
Illumina Inc
276.67 41.78B 4.39B 853.00M 556.00M 5.5097
TMO icon
TMO
Thermo Fisher Scientific Inc
662.24 244.86B 45.20B 6.87B 6.75B 18.19
DHR icon
DHR
Danaher Corp
221.20 155.50B 24.78B 3.68B 5.29B 5.1743
NTRA icon
NTRA
Natera Inc
397.77 57.34B 2.50B -226.32M 71.51M -1.6412
A icon
A
Agilent Technologies Inc
171.33 48.30B 7.23B 1.41B 1.09B 4.979
IQV icon
IQV
Iqvia Holdings Inc
262.21 43.16B 16.63B 1.39B 2.12B 8.0674

Illumina Inc Stock (ILMN) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-09-09 再開されました UBS Buy
2026-06-26 再開されました Bernstein Mkt Perform
2026-06-10 アップグレード JP Morgan Neutral → Overweight
2026-05-15 再開されました RBC Capital Mkts Outperform
2026-05-14 アップグレード Daiwa Securities Neutral → Outperform
2025-08-12 ダウングレード Daiwa Securities Outperform → Neutral
2025-07-11 ダウングレード Scotiabank Sector Outperform → Sector Perform
2025-03-04 繰り返されました Citigroup Neutral
2025-02-28 ダウングレード HSBC Securities Buy → Hold
2025-02-10 ダウングレード Barclays Equal Weight → Underweight
2025-02-07 ダウングレード TD Cowen Buy → Hold
2024-12-11 ダウングレード Citigroup Buy → Neutral
2024-11-12 再開されました Morgan Stanley Equal-Weight
2024-10-17 アップグレード HSBC Securities Hold → Buy
2024-08-28 アップグレード Argus Hold → Buy
2024-08-16 アップグレード Daiwa Securities Neutral → Buy
2024-08-14 アップグレード Barclays Underweight → Equal Weight
2024-08-14 アップグレード TD Cowen Hold → Buy
2024-07-10 アップグレード Citigroup Neutral → Buy
2024-06-03 再開されました Jefferies Hold
2024-01-16 ダウングレード HSBC Securities Buy → Hold
2024-01-04 ダウングレード TD Cowen Outperform → Market Perform
2023-12-18 アップグレード Scotiabank Sector Perform → Sector Outperform
2023-12-15 アップグレード Bernstein Underperform → Mkt Perform
2023-12-14 開始されました Guggenheim Buy
2023-12-14 開始されました Stephens Overweight
2023-12-13 開始されました Wolfe Research Outperform
2023-12-12 ダウングレード BofA Securities Neutral → Underperform
2023-12-11 アップグレード Citigroup Sell → Neutral
2023-11-10 ダウングレード Canaccord Genuity Buy → Hold
2023-09-28 開始されました Bernstein Underperform
2023-07-05 再開されました JP Morgan Neutral
2023-01-25 ダウングレード Argus Buy → Hold
2023-01-05 開始されました Scotiabank Sector Perform
2022-12-12 ダウングレード Citigroup Neutral → Sell
2022-12-07 開始されました RBC Capital Mkts Outperform
2022-10-04 アップグレード SVB Leerink Mkt Perform → Outperform
2022-09-28 アップグレード Evercore ISI In-line → Outperform
2022-08-25 開始されました Credit Suisse Neutral
2022-07-13 ダウングレード Barclays Equal Weight → Underweight
2022-01-18 アップグレード Stifel Hold → Buy
2022-01-11 アップグレード Barclays Underweight → Equal Weight
2022-01-07 アップグレード BofA Securities Underperform → Neutral
2022-01-06 再開されました Morgan Stanley Equal-Weight
2022-01-06 再開されました Piper Sandler Overweight
2021-10-15 再開されました Cowen Outperform
2021-08-19 ダウングレード SVB Leerink Outperform → Mkt Perform
2021-06-01 アップグレード Evercore ISI Underperform → In-line
2021-03-31 ダウングレード Atlantic Equities Overweight → Neutral
2021-03-31 アップグレード Canaccord Genuity Hold → Buy
2021-03-03 開始されました Barclays Underweight
2020-12-22 アップグレード Piper Sandler Neutral → Overweight
2020-12-17 アップグレード BTIG Research Neutral → Buy
2020-10-13 ダウングレード Guggenheim Buy → Neutral
2020-09-30 開始されました Atlantic Equities Overweight
2020-09-29 ダウングレード Wolfe Research Outperform → Peer Perform
2020-09-22 ダウングレード Stifel Buy → Hold
2020-09-22 ダウングレード UBS Buy → Neutral
2020-09-21 アップグレード Guggenheim Neutral → Buy
2020-09-21 ダウングレード JP Morgan Overweight → Neutral
2020-09-09 開始されました Morgan Stanley Equal-Weight
2020-08-07 ダウングレード Evercore ISI In-line → Underperform
2020-08-07 ダウングレード Piper Sandler Overweight → Neutral
2020-07-07 ダウングレード Guggenheim Buy → Neutral
2020-04-24 ダウングレード Citigroup Buy → Neutral
2020-04-21 ダウングレード Robert W. Baird Outperform → Neutral
2020-01-08 開始されました Wells Fargo Underweight
2020-01-07 開始されました Citigroup Buy
2020-01-02 ダウングレード Evercore ISI Outperform → In-line
2019-11-15 開始されました Stifel Buy
2019-10-25 開始されました Guggenheim Buy
すべてを表示

Illumina Inc (ILMN) 最新ニュース

pulisher
Oct 11, 2026

Introducing SpliceAI2: The Next Generation of Splicing and Transcript Isoform Prediction - Illumina

Oct 11, 2026
pulisher
Oct 09, 2026

Illumina Inc (ILMN) Stock Up 5.1% but GF Value Says Overvalued -- GF Score: 65/100 - GuruFocus

Oct 09, 2026
pulisher
Oct 09, 2026

Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch

Oct 09, 2026
pulisher
Oct 09, 2026

Illumina, Inc. Stock 12‑Month Price Target Raised to $237.16, Implies 10% Downside - TradingView

Oct 09, 2026
pulisher
Oct 08, 2026

What is Illumina’s (ILMN) Economic Moat, and is it Widening or Narrowing? - Yahoo Finance

Oct 08, 2026
pulisher
Oct 08, 2026

Illumina to Announce Third Quarter 2026 Financial Results on Thursday, October 29, 2026 - Investing News Network

Oct 08, 2026
pulisher
Oct 08, 2026

Illumina, Inc. Initiates Recall of NovaSeq 6000Dx Including DRAGEN Server And Illumina DRAGEN Server For NextSeq 550Dx - www.marketscreener.com

Oct 08, 2026
pulisher
Oct 08, 2026

Illumina Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Oct 08, 2026
pulisher
Oct 08, 2026

Illumina to Announce Third Quarter 2026 Financial Results on Thursday, October 29, 2026 - Illumina

Oct 08, 2026
pulisher
Oct 08, 2026

Illumina releases SpliceAI2 to help advance rare disease research - PR Newswire

Oct 08, 2026
pulisher
Oct 07, 2026

After shares were delivered or withheld for exercise price or tax liability, Illumina (ILMN) CEO holds 107,770 shares. - Stock Titan

Oct 07, 2026
pulisher
Oct 07, 2026

Illumina Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Oct 07, 2026
pulisher
Oct 07, 2026

She transformed genomics. Multiomics is next: The Sequence - Illumina

Oct 07, 2026
pulisher
Oct 07, 2026

With voting power over 15.4M shares, FMR reports a passive stake in Illumina (ILMN). - Stock Titan

Oct 07, 2026
pulisher
Oct 06, 2026

Global Microfluidics Market by Product Type, Application, End User, and Region, 2026-2036 | $48.04 Billion Opportunity Driven by Point-of-Care Diagnostics and Automation - GlobeNewswire Inc.

Oct 06, 2026
pulisher
Oct 06, 2026

RBC raises target for Illumina stock to USD 310 - AD HOC NEWS

Oct 06, 2026
pulisher
Oct 05, 2026

Illumina (ILMN) Shares Skyrocket, What You Need To Know - Yahoo Finance

Oct 05, 2026
pulisher
Oct 05, 2026

Illumina (ILMN) Shares Skyrocket, What You Need To Know - FinancialContent

Oct 05, 2026
pulisher
Oct 05, 2026

Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch

Oct 05, 2026
pulisher
Oct 05, 2026

Illumina stock gains 7.95 percent as RBC raises target - AD HOC NEWS

Oct 05, 2026
pulisher
Oct 05, 2026

Illumina Inc Stock (ILMN) Moved Up by 7.85% on Oct 5: Drivers Behind the Movement - TradingKey

Oct 05, 2026
pulisher
Oct 05, 2026

Illumina rises as recent analyst target hikes and index inclusion keep momentum intact - Quiver Quantitative

Oct 05, 2026
pulisher
Oct 05, 2026

Illumina stock hits 52-week high at 280.44 USD By Investing.com - Investing.com South Africa

Oct 05, 2026
pulisher
Oct 05, 2026

Illumina stock hits 52-week high at 280.44 USD - Investing.com

Oct 05, 2026
pulisher
Oct 05, 2026

Illumina's Clinical Sequencing Revenue Seen as Durable Mid-Teens Grower, RBC Capital Markets Says - marketscreener.com

Oct 05, 2026
pulisher
Oct 05, 2026

Illumina's Clinical Sequencing Revenue Seen as Durable Mid-Teens Grower, RBC Capital Markets Says - Yahoo Finance

Oct 05, 2026
pulisher
Oct 05, 2026

RBC Capital raises Illumina stock price target on clinical sales - Investing.com

Oct 05, 2026
pulisher
Oct 05, 2026

RBC Capital maintains Outperform rating on Illumina, $310 price target - TradingView

Oct 05, 2026
pulisher
Oct 05, 2026

RBC raises target for Illumina stock to USD 310 - AD HOC NEWS

Oct 05, 2026
pulisher
Oct 05, 2026

Illumina Inc : RBC Raises Target Price to $31 - Moomoo

Oct 05, 2026
pulisher
Oct 05, 2026

Immunogenomics Market Size, Share, Trends, and Growth Forecast, 2026-2033 | NGS and Personalized Medicine Drive Market Toward USD 9.82 Billion at 5.97% CAGR - GlobeNewswire Inc.

Oct 05, 2026
pulisher
Oct 02, 2026

Form 4 Illumina Inc For: 2 October By Investing.com - Investing.com South Africa

Oct 02, 2026
pulisher
Oct 02, 2026

A director receives 107 shares instead of cash for quarterly retainer fees at Illumina (ILMN). - Stock Titan

Oct 02, 2026
pulisher
Oct 02, 2026

A director receives stock for 100% of Q3 retainer fees at Illumina (ILMN) - Stock Titan

Oct 02, 2026
pulisher
Oct 02, 2026

Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch

Oct 02, 2026
pulisher
Oct 02, 2026

Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch

Oct 02, 2026
pulisher
Oct 02, 2026

Illumina, Inc. (ILMN) Stock Forecasts - Yahoo Finance

Oct 02, 2026
pulisher
Oct 01, 2026

Illumina Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Oct 01, 2026
pulisher
Oct 01, 2026

Global Liver Cancer Diagnostics Market to Observe Impressive Growth at a CAGR of ~9% by 2034 | DelveInsight - GlobeNewswire Inc.

Oct 01, 2026
pulisher
Sep 30, 2026

3 Reasons to Buy Grail (GRAL) Hand Over Fist in October - The Motley Fool

Sep 30, 2026
pulisher
Sep 30, 2026

The Benchmark Matters: Evaluating TruPath Genome Beyond Individual Loci - Illumina

Sep 30, 2026
pulisher
Sep 29, 2026

Where Will Illumina Stock Be in 5 Years If Its AI Bet Pays Off? - The Motley Fool

Sep 29, 2026
pulisher
Sep 29, 2026

REGN or ILMN: Which Is the Better Value Stock Right Now? - Zacks Investment Research

Sep 29, 2026
pulisher
Sep 28, 2026

Is the Options Market Predicting a Spike in Illumina Stock? - Yahoo Finance

Sep 28, 2026
pulisher
Sep 25, 2026

Illumina Inc. stock underperforms Friday when compared to competitors - MarketWatch

Sep 25, 2026
pulisher
Sep 24, 2026

Illumina stock adds 3.20 percent ahead of the open - AD HOC NEWS

Sep 24, 2026
pulisher
Sep 23, 2026

Will Index Reshuffle Change Illumina (ILMN) Narrative - simplywall.st

Sep 23, 2026
pulisher
Sep 22, 2026

Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch

Sep 22, 2026
pulisher
Sep 22, 2026

Here's How Much $1000 Invested In Illumina 20 Years Ago Would Be Worth Today - Benzinga

Sep 22, 2026
pulisher
Sep 22, 2026

Illumina stock holds near its yearly high as targets diverge - AD HOC NEWS

Sep 22, 2026

Illumina Inc (ILMN) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Illumina Inc (ILMN) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Corvex Management LP
Affiliate of Director (1)
Sep 04 '26
Proposed Sale
213.25
150,000
31,987,500
0
Meister Keith A.
Director
Sep 03 '26
Sale
218.23
75,951
16,574,481
889,851
Meister Keith A.
Director
Sep 02 '26
Sale
213.28
68,108
14,526,254
965,802
Corvex Management LP
Affiliate of Director (1)
Aug 27 '26
Proposed Sale
224.84
200,000
44,968,000
0
Meister Keith A.
Director
Aug 27 '26
Sale
228.89
138,379
31,673,778
1,033,910
Meister Keith A.
Director
Aug 26 '26
Sale
225.46
106,543
24,021,247
1,172,289
Corvex Management LP
Affiliate of Director (1)
Aug 25 '26
Proposed Sale
223.22
300,000
66,966,000
0
Meister Keith A.
Director
Aug 25 '26
Sale
225.51
131,019
29,546,639
1,278,832
Meister Keith A.
Director
Aug 21 '26
Sale
217.96
299,336
65,243,445
1,409,851
Corvex Management LP
Affiliate of Director (1)
Aug 21 '26
Proposed Sale
213.24
250,000
53,310,000
0
$523.94
price up icon 1.15%
WAT WAT
$432.10
price down icon 0.38%
IQV IQV
$262.21
price up icon 0.90%
A A
$171.33
price up icon 0.46%
MTD MTD
$1,563.01
price up icon 0.84%
$397.77
price down icon 0.73%
大文字化:     |  ボリューム (24 時間):